Painreform is trading 10.42% down at $0.70, with no direct catalyst confirmed.
- The decline follows a $0.78 close on October 16, when the stock was already down 7.64%.
- No company-specific announcement explaining the October 19 drop appeared in available search results; the investor-relations page’s latest listed update is dated October 16.
- Major indices were higher in the supplied market context, so broad market weakness does not clearly explain the move.